usps-logo.jpg?1721728722
Ultrafast Ultrasonic Synthesis
Catalog peptides: immediate delivery
ISO 9001/2015 certified
1000 peptides & peptide pools
30 years of experience in peptide synthesis

BCR/ABL 210 kD fusion protein 259-269 (HLA-A*03:01) (HLA-A*11:01)
( ATGFKQSSK )



This peptide has high avidity for CD8 T cells, and can be used in the analysis of individual antigen-specific T cells. This product is a MHC pentamer of peptide composed BCR-ABL 210 kD fusion protein-derived peptide of ATGFKQSSK sequence covering 259-269 and A*03:01, A*11:01 molecule.

Sequence:ATGFKQSSK
Gene:BCR
Delivery: 3 weeks
C-Terminus:OH
N-Terminus:H
Amount:1 mg
Counter Ion:TFA
Protein:Human Bcr-abl 210 kD fusion protein
Species:Human
Allele:HLA-A*03:01 HLA-A*11:01
Application :Flow Cytometry
Indication :Cancer
Purity :95% HPLC-MS
Special references for this product will come soon.
For your convenience, we have compiled a selection of publications
where our peptide products have been employed:
Publications >

€60.40*

Delivery time 2-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity: 95% HPLC-MS
Amount in mg
Product number: EP11088_1